News
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S. pharmacy claims.
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...
Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main rival Wegovy from Novo Nordisk. The full data from the 751-subject SURMOUNT-5 ...
Though Zepbound led to greater weight loss, factors such as insurance coverage and secondary treatment indications can impact whether Zepbound or Wegovy is right for you.
Zepbound growth has outpaced Wegovy in recent months, and sales quadrupled to $2.31 billion in the first three months of this year compared to the same period of 2024, while Mounjaro more than ...
More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment.
Lilly's recent agreements with telehealth firms like Ro and LifeMD prohibit them from selling copycat versions of Lilly's Zepbound and Novo's Wegovy.
There are other weight loss medications available, including injections, like Wegovy and Zepbound, and pills like metformin.
(Reuters) -Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website starting early August, the U.S. drugmaker said on Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results